Clinical trial
The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection
NCT03273231 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 1, 2017
- Completion date
- July 31, 2020
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer